Document is current

Any future updates will be listed below

Correction to: Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double‑Blind, Phase 3 Trials

Crossref DOI link: https://doi.org/10.1007/s40257-025-00989-x

Published Online: 2025-11-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark